Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).
Almost 70% of urinary bladder neoplasms present as low-grade papillary noninvasive tumors (stage pTa). To determine which genomic alterations can occur in pTa tumors of different grades and to evaluate the prognostic significance of chromosomal imbalances, we analyzed 113 pTa tumors (40 grade 1, 55 grade 2, 18 grade 3) by comparative genomic hybridization. pTaG1 (1.9 +/- 2.0) and pTaG2 (3.1 +/- 2.9) tumors had only few genomic alterations with 9q- (44%), 9p- (36%), and -Y (21%) being most prevalent. Neither the total number of aberrations nor any individual alteration was linked to the risk of recurrence in 95 pTaG1/G2 tumors with clinical follow-up information. pTaG3 tumors were characterized by a high number of alterations (7.7 +/- 4.5; P < 0.0001 for G3 versus G2). Several chromosomal imbalances that have previously been reported to be typical for invasive bladder neoplasms were significantly more frequent in pTaG3 than in pTaG2 tumors, including 2q-, 5p+, 5q-, 6q-, 8p-, 10q-, 18q-, and 20q+. A malfunction of genes at these loci may contribute to the development of high-grade urothelial neoplasias. However, there is no evidence for a direct role of these alterations for development of invasive tumor growth.
Zhao
J
J
Institute of Pathology, University of Basel, Switzerland.
Richter
J
J
Wagner
U
U
Roth
B
B
Schraml
P
P
Zellweger
T
T
Ackermann
D
D
Schmid
U
U
Moch
H
H
Mihatsch
M J
MJ
Gasser
T C
TC
Sauter
G
G
D002278:Carcinoma in Situ / Q000235:genetics / Q000473:pathology; D002291:Carcinoma, Papillary / Q000235:genetics* / Q000473:pathology; D002869:Chromosome Aberrations; D002874:Chromosome Mapping; D002899:Chromosomes, Human, Pair 9; D018572:Disease-Free Survival; D006801:Humans; D019656:Loss of Heterozygosity; D009367:Neoplasm Staging; D011379:Prognosis; D012008:Recurrence; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000473:pathology